BNP Paribas Financial Markets’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.91M | Buy |
148,579
+86,596
| +140% | +$4.16M | ﹤0.01% | 1870 |
|
|
2026
Q1 | $3.2M | Sell |
61,983
-15,647
| -20% | -$797K | ﹤0.01% | 2353 |
|
|
2025
Q4 | $3.86M | Sell |
77,630
-338,060
| -81% | -$16.4M | ﹤0.01% | 2212 |
|
|
2025
Q3 | $19.9M | Buy |
415,690
+113,025
| +37% | +$4.55M | 0.01% | 1125 |
|
|
2025
Q2 | $9.54M | Buy |
302,665
+42,604
| +16% | +$1.37M | 0.01% | 1478 |
|
|
2025
Q1 | $8.52M | Sell |
260,061
-32,568
| -11% | -$1.15M | 0.01% | 1493 |
|
|
2024
Q4 | $10.6M | Buy |
292,629
+208,552
| +248% | +$7.34M | 0.01% | 1329 |
|
|
2024
Q3 | $2.62M | Buy |
84,077
+11,125
| +15% | +$347K | ﹤0.01% | 1897 |
|
|
2024
Q2 | $1.95M | Sell |
72,952
-4,908
| -6% | -$142K | ﹤0.01% | 1933 |
|
|
2024
Q1 | $2.66M | Buy |
77,860
+24,428
| +46% | +$727K | ﹤0.01% | 1874 |
|
|
2023
Q4 | $1.55M | Buy |
53,432
+14,129
| +36% | +$375K | ﹤0.01% | 2122 |
|
|
2023
Q3 | $1.08M | Buy |
39,303
+25,773
| +190% | +$785K | ﹤0.01% | 2281 |
|
|
2023
Q2 | $407K | Sell |
13,530
-11,483
| -46% | -$402K | ﹤0.01% | 2693 |
|
|
2023
Q1 | $906K | Buy |
25,013
+7,773
| +45% | +$299K | ﹤0.01% | 2386 |
|
|
2022
Q4 | $615K | Buy |
+17,240
| New | +$599K | ﹤0.01% | 2455 |
|
|
2022
Q3 | – | Sell |
-23,262
| Closed | -$673K | – | 5014 |
|
|
2022
Q2 | $673K | Buy |
23,262
+5,921
| +34% | +$170K | ﹤0.01% | 2480 |
|
|
2022
Q1 | $560K | Sell |
17,341
-43,179
| -71% | -$1.32M | ﹤0.01% | 2688 |
|
|
2021
Q4 | $1.76M | Buy |
60,520
+5,940
| +11% | +$180K | ﹤0.01% | 2147 |
|
|
2021
Q3 | $1.46M | Buy |
54,580
+30,627
| +128% | +$822K | ﹤0.01% | 2121 |
|
|
2021
Q2 | $738K | Buy |
23,953
+1,040
| +5% | +$31.9K | ﹤0.01% | 2348 |
|
|
2021
Q1 | $600K | Buy |
22,913
+6,813
| +42% | +$191K | ﹤0.01% | 2466 |
|
|
2020
Q4 | $405K | Buy |
16,100
+2,398
| +18% | +$51.6K | ﹤0.01% | 2569 |
|
|
2020
Q3 | $286K | Sell |
13,702
-13,100
| -49% | -$297K | ﹤0.01% | 2549 |
|
|
2020
Q2 | $637K | Sell |
26,802
-99,054
| -79% | -$2.19M | ﹤0.01% | 1994 |
|
|
2020
Q1 | $2.26M | Buy |
125,856
+113,357
| +907% | +$2.38M | ﹤0.01% | 1414 |
|
|
2019
Q4 | $296K | Buy |
12,499
+3,555
| +40% | +$86.3K | ﹤0.01% | 2775 |
|
|
2019
Q3 | $246K | Buy |
8,944
+2,367
| +36% | +$70.1K | ﹤0.01% | 2641 |
|
|
2019
Q2 | $218K | Sell |
6,577
-4,768
| -42% | -$163K | ﹤0.01% | 2570 |
|
|
2019
Q1 | $398K | Buy |
11,345
+10,176
| +870% | +$379K | ﹤0.01% | 2248 |
|
|
2018
Q4 | $38.8K | Sell |
1,169
-2,532
| -68% | -$109K | ﹤0.01% | 2838 |
|
|
2018
Q3 | $186K | Sell |
3,701
-4,569
| -55% | -$226K | ﹤0.01% | 2433 |
|
|
2018
Q2 | $495K | Sell |
8,270
-11,388
| -58% | -$590K | ﹤0.01% | 2017 |
|
|
2018
Q1 | $900K | Sell |
19,658
-1,006
| -5% | -$42K | ﹤0.01% | 1814 |
|
|
2017
Q4 | $823K | Sell |
20,664
-5,408
| -21% | -$214K | ﹤0.01% | 2117 |
|
|
2017
Q3 | $1.04M | Buy |
26,072
+11,038
| +73% | +$478K | ﹤0.01% | 1532 |
|
|
2017
Q2 | $648K | Sell |
15,034
-123,726
| -89% | -$4.4M | ﹤0.01% | 1767 |
|
|
2017
Q1 | $4.34M | Buy |
138,760
+128,598
| +1,265% | +$3.45M | 0.01% | 808 |
|
|
2016
Q4 | $257K | Buy |
10,162
+3,304
| +48% | +$73.8K | ﹤0.01% | 2058 |
|
|
2016
Q3 | $170K | Sell |
6,858
-4,620
| -40% | -$105K | ﹤0.01% | 1832 |
|
|
2016
Q2 | $234K | Buy |
11,478
+6,407
| +126% | +$114K | ﹤0.01% | 1840 |
|
|
2016
Q1 | $77.3K | Sell |
5,071
-2,083
| -29% | -$27.2K | ﹤0.01% | 1875 |
|
|
2015
Q4 | $96.2K | Sell |
7,154
-673
| -9% | -$10.4K | ﹤0.01% | 2361 |
|
|
2015
Q3 | $110K | Buy |
7,827
+4,969
| +174% | +$92.4K | ﹤0.01% | 2332 |
|
|
2015
Q2 | $48.5K | Buy |
2,858
+2,177
| +320% | +$31K | ﹤0.01% | 2513 |
|
|
2015
Q1 | $8.23K | Buy |
+681
| New | +$6.43K | ﹤0.01% | 2861 |
|
|
2014
Q4 | – | Sell |
-2,248
| Closed | -$19.5K | – | 3040 |
|
|
2014
Q3 | $19.5K | Buy |
+2,248
| New | +$20.3K | ﹤0.01% | 3180 |
|
|
2014
Q2 | – | Sell |
-62
| Closed | -$509 | – | 3938 |
|
|
2014
Q1 | $509 | Sell |
62
-138
| -69% | -$1.27K | ﹤0.01% | 3039 |
|
|
2013
Q4 | $1.51K | Buy |
+200
| New | +$1.4K | ﹤0.01% | 3763 |
|
Other funds holding SUPN
AC
NAMI
SIMG
BNP Paribas Financial Markets's SUPN Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Supernus Pharmaceuticals (SUPN) stake by 140% in Q2 2026, buying an estimated $4.16M and bringing the position to 148,579 shares worth $6.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1870.
BNP Paribas Financial Markets first reported a position in SUPN in Q4 2013 and has held it in 48 quarters since. The position peaked at $19.9M in Q3 2025. 311 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- BNP Paribas Financial Markets held 148,579 shares of Supernus Pharmaceuticals worth $6.91M as of Q2 2026.
- BNP Paribas Financial Markets bought 86,596 Supernus Pharmaceuticals shares in Q2 2026, an estimated $4.16M.
- Supernus Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1870 holding.
- BNP Paribas Financial Markets first reported a position in Supernus Pharmaceuticals in Q4 2013 and has held it in 48 quarters since.
- BNP Paribas Financial Markets's Supernus Pharmaceuticals position peaked at $19.9M in Q3 2025.
- 311 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.